Author

Martin Škandík

Karolinska InstitutetORCID 0000-0003-2060-9553Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1

Frequent Co-Authors

Adamantia F. FragopoulouiD· 1 shared Adriana‐Natalia MurgociiD· 1 shared Ahmed M. OsmaniD· 1 shared Anastasios E. DamdimopoulosiD· 1 shared Bertrand JosephiD· 1 shared Carlos Fernando Dias RodriguesiD· 1 shared Christine Hong· 1 shared Fredrik KammeiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Adamantia F. FragopoulouORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintFeb 22, 2025

Glioma-induced DNMT3A-dependent reduction of DNA methylation in microglia promotes a transient anti-tumoral phenotype.

Mathilde Cheray, Adriana‐Natalia Murgoci, Adamantia F. Fragopoulou…·Bertrand Joseph

This study shows that glioma-induced DNMT3A reduction in microglia leads to DNA demethylation and an anti-tumoral phenotype, suggesting DNMT3A as a therapeutic target for glioblastoma.

DOI 10.1101/2025.02.22.639606

mousebulk RNA-seq

𝕏 PostBluesky